tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Cyclerion Therapeutics Inc

CYCN
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
3.440USD
-0.060-1.71%
์ข…๊ฐ€ย 07-31 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
14.59M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

CYCN ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Cyclerion Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Cyclerion Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
May 12, 2026
EPS / ์˜ˆ์ƒ
-0.76/--
์ˆ˜์ต / ์˜ˆ์ƒ
0.00/--
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
2.07M
3.70%
EPS(YoY)
-1.11
8.65%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
2026/07/31
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-35.14%-0.76
-200.56%-0.21
-5.74%-0.30
79.97%-0.11
9.57%-0.56
130.22%0.21
-109.21%-0.29
71.25%-0.53
80.65%-0.62
79.22%-0.69
--3.11
---1.83
---3.20
---3.32
----
----
----
----
----
----
์ˆ˜์ต
-100.00%0.00
-43.24%1.02M
351.03%875.00K
--93.00K
--81.00K
--1.81M
--194.00K
----
----
--0.00
--0.00
----
----
-100.00%0.00
-100.00%0.00
-89.80%306.00K
1046.77%711.00K
300.75%533.00K
-13.00%348.00K
300.53%3.00M
์ˆœ์ด์ต
-122.32%-3.18M
-250.75%-799.00K
-34.99%-976.00K
75.49%-324.00K
7.33%-1.43M
131.29%530.00K
-109.56%-723.00K
68.38%-1.32M
77.83%-1.54M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
33.03%-7.22M
7.03%-10.50M
17.27%-13.39M
3.14%-12.98M
43.96%-10.78M
39.99%-11.29M
17.16%-16.18M
์ˆœ์ด์ต๋ฅ 
----
-365.62%-77.95%
70.07%-111.54%
---348.39%
---1764.20%
--29.35%
---372.68%
----
----
----
----
----
----
----
----
----
----
----
----
----
์ด ์ด์ต๋ฅ 
----
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
์ˆ˜์ต
-100.00%0.00
-43.24%1.02M
351.03%875.00K
--93.00K
--81.00K
--1.81M
--194.00K
----
----
--0.00
--0.00
----
----
-100.00%0.00
-100.00%0.00
-89.80%306.00K
1046.77%711.00K
300.75%533.00K
-13.00%348.00K
300.53%3.00M
์˜์—… ์ด์ต
-120.25%-3.21M
-266.93%-838.00K
10.82%-1.01M
-20.81%-1.67M
9.95%-1.46M
127.97%502.00K
58.39%-1.13M
25.79%-1.38M
50.60%-1.62M
59.71%-1.79M
40.00%-2.71M
86.12%-1.86M
74.78%-3.27M
68.93%-4.46M
59.96%-4.52M
12.17%-13.43M
3.07%-12.98M
25.42%-14.34M
47.11%-11.29M
23.03%-15.29M
์ˆœ์ด์ต
-122.32%-3.18M
-250.75%-799.00K
-34.99%-976.00K
75.49%-324.00K
7.33%-1.43M
131.29%530.00K
-109.56%-723.00K
68.38%-1.32M
77.83%-1.54M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
33.03%-7.22M
7.03%-10.50M
17.27%-13.39M
3.14%-12.98M
43.96%-10.78M
39.99%-11.29M
17.16%-16.18M
์œ ๋™์ž์‚ฐ
-31.31%3.09M
9.70%4.63M
42.76%5.07M
-14.74%4.02M
-25.22%4.50M
-47.35%4.22M
-64.03%3.55M
-33.71%4.71M
-27.85%6.01M
-45.86%8.02M
-54.45%9.86M
-77.55%7.11M
-80.54%8.34M
-73.28%14.82M
-65.99%21.66M
-56.60%31.68M
-3.62%42.84M
-5.20%55.46M
-9.19%63.68M
22.54%72.99M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
60.64%1.71M
24.14%900.00K
25.29%877.00K
-37.60%800.00K
-25.95%1.07M
-65.24%725.00K
-70.10%700.00K
-74.09%1.28M
-80.87%1.44M
-72.65%2.09M
-72.55%2.34M
-49.79%4.95M
-20.65%7.53M
-31.20%7.63M
-24.89%8.53M
-6.26%9.85M
-29.52%9.49M
-34.61%11.09M
-30.17%11.36M
-32.82%10.51M
์ด ์ž์‚ฐ
-13.63%8.51M
4.28%9.98M
17.05%10.41M
-6.91%9.37M
-13.35%9.85M
-28.41%9.57M
-41.51%8.90M
-0.32%10.06M
-0.80%11.36M
-26.02%13.37M
-39.27%15.21M
-71.33%10.10M
-75.38%11.46M
-69.53%18.08M
-63.02%25.05M
-53.50%35.21M
-53.46%46.52M
-48.58%59.33M
-48.45%67.74M
-40.85%75.73M
๋ถ€์ฑ„ ์ด๊ณ„
60.64%1.71M
24.14%900.00K
25.29%877.00K
-37.60%800.00K
-25.95%1.07M
-65.24%725.00K
-70.10%700.00K
-74.09%1.28M
-80.87%1.44M
-72.65%2.09M
-72.55%2.34M
-49.79%4.95M
-20.65%7.53M
-31.20%7.63M
-24.89%8.53M
-6.26%9.85M
-81.58%9.49M
-80.16%11.09M
-79.74%11.36M
-83.03%10.51M
์ž๋ณธ ์ด๊ณ„
-22.65%6.79M
2.66%9.09M
16.35%9.54M
-2.43%8.57M
-11.52%8.78M
-21.60%8.85M
-36.32%8.20M
70.54%8.78M
152.82%9.92M
8.00%11.29M
-22.10%12.87M
-79.69%5.15M
-89.40%3.92M
-78.34%10.45M
-70.70%16.52M
-61.12%25.36M
-23.54%37.03M
-18.90%48.25M
-25.17%56.39M
-1.33%65.22M
์ˆœ์˜์—…์ด์ต
-21.49%-1.18M
-538.61%-1.58M
84.62%-264.00K
54.52%-503.00K
48.26%-968.00K
123.36%360.00K
75.26%-1.72M
83.13%-1.11M
69.89%-1.87M
78.12%-1.54M
30.06%-6.94M
39.41%-6.55M
51.59%-6.21M
18.39%-7.04M
-25.14%-9.91M
-96.37%-10.82M
11.21%-12.84M
38.54%-8.63M
47.35%-7.92M
61.26%-5.51M
์ˆœํˆฌ์ž
---66.00K
----
----
----
----
--0.00
-100.00%0.00
----
----
--0.00
--10.40M
----
----
--0.00
100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-333.33%-7.00K
103.08%2.00K
์ˆœ์žฌ๋ฌดํ™œ๋™
-40.00%825.00K
--251.00K
--1.83M
---130.00K
--1.38M
--0.00
--0.00
----
----
-100.00%0.00
--0.00
29452.94%5.02M
----
-85.88%12.00K
-100.00%0.00
-99.94%17.00K
-100.00%0.00
-46.54%85.00K
-99.82%43.00K
736.20%30.63M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Cyclerion Therapeutics Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cyclerion Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 2.07M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2.00M์ž…๋‹ˆ๋‹ค.

Cyclerion Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cyclerion Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 4.63M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 9.70์ž…๋‹ˆ๋‹ค.

Cyclerion Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cyclerion Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Cyclerion Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 9.98M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 4.28์ž…๋‹ˆ๋‹ค.

Cyclerion Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cyclerion Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Cyclerion Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 900.00K์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 24.14์ž…๋‹ˆ๋‹ค.

Cyclerion Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cyclerion Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Cyclerion Therapeutics Inc์˜ ์ด์ž๋ณธ์€ 9.09M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2.66์ž…๋‹ˆ๋‹ค.

Cyclerion Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cyclerion Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Cyclerion Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -4.97M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -37.07์ž…๋‹ˆ๋‹ค.

Cyclerion Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cyclerion Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -1.11์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 8.65์ž…๋‹ˆ๋‹ค.

Cyclerion Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cyclerion Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -3.53M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -15.41์ž…๋‹ˆ๋‹ค.

Cyclerion Therapeutics Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cyclerion Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -170.11์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -11.29์ž…๋‹ˆ๋‹ค.

Cyclerion Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cyclerion Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -39.34์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -29.58์ž…๋‹ˆ๋‹ค.

Cyclerion Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cyclerion Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -36.07์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -35.40์ž…๋‹ˆ๋‹ค.

Cyclerion Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Cyclerion Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -4.97M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -37.07์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ